title: Alterations in erythrocyte membrane lipid and fatty acid composition in Chediak-Higashi syndrome.
abstract: Chediak-Higashi syndrome (CHS) is an autosomal recessive disease characterized by the presence of abnormally large cytoplasmic organelles in all body granule producing cells. The molecular mechanism for this disease is still unknown. Functional disorders in membrane-related processes have been reported. Erythrocyte membranes from four CHS patients and 15 relatives including obligatory heterozygous were studied to examine potential alterations in the lipid and fatty acid profile of erythrocyte membranes associated with this syndrome. Plasma concentrations of cholesterol, triglycerides, phospholipids, and apolipoproteins AI and B100, and the lipid components of very low-, intermediate-, low- and high-density lipoproteins were also determined. CHS erythrocyte membranes were found to be enriched with lipids in relation to protein and to show: (1) an increase in cholesterol and choline-containing phospholipids (sphingomyelin and phosphatidylcholine) that predominate in the outer monolayer, which is higher than the increase in phosphatidylserine and phosphatidylethanolamine, that are chiefly limited to the inner monolayer in normal red blood cells; (2) a relative palmitic acid and saturated fatty acid increase and arachidonic acid and unsaturated fatty acid decrease, this resulting in a lower unsaturation index than controls. Changes in CHS erythrocyte membrane lipids seem to be unrelated to serum lipid disorders as plasma lipid and apolipoprotein concentrations were apparently in the normal range, with the exception of a modest hypertriglyceridemia in patients and relatives and a decreased concentration of HDL cholesterol in patients. These findings indicate that CHS erythrocyte membranes contain an abnormal lipid matrix with which membrane proteins are defectively associated. The anomalous CHS membrane composition can be explained on the postulated effects of the CHS1/Lyst gene.
authors.affiliation: Department of Physiology, University of the Basque Country Medical School, Bilbao, Spain.
authors.forename: Y
authors.initials: Y
authors.lastname: Chico
authors.forename: M
authors.initials: M
authors.lastname: Lafita
authors.forename: P
authors.initials: P
authors.lastname: Ramírez-Duque
authors.forename: F
authors.initials: F
authors.lastname: Merino
authors.forename: B
authors.initials: B
authors.lastname: Ochoa
mesh_terms: D000293:Adolescent; D000328:Adult; D002609:Chediak-Higashi Syndrome / Q000097:blood / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D004910:Erythrocyte Membrane / Q000737:chemistry / Q000378:metabolism*; D005227:Fatty Acids / Q000032:analysis*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008563:Membrane Lipids / Q000097:blood* / Q000737:chemistry; D008565:Membrane Proteins / Q000097:blood; D010743:Phospholipids / Q000097:blood / Q000737:chemistry
chemical_list: D005227:Fatty Acids; D008074:Lipoproteins; D008563:Membrane Lipids; D008565:Membrane Proteins; D010743:Phospholipids